Granza Bio (YC W24)

Granza Bio (YC W24)

Biotechnology Research

Advancing Therapeutic Delivery using Precision Shells

About us

Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues. For their lead candidate, Granza Bio is leveraging the discovery of the immune system’s powerful suite of weapons, “attack particles”. Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections. Interested to know more?

Industry
Biotechnology Research
Company size
2-10 employees
Type
Privately Held
Founded
2023

Employees at Granza Bio (YC W24)

Updates

Similar pages

Funding